More Talks Needed With China and Japan For Cooperation In Sharing Clinical Data - Korea FDA Official
This article was originally published in PharmAsia News
SEOUL - Although drug regulatory officials from South Korea, Japan and China met in Beijing for two days from Dec. 17 in their second tri-party meeting, they failed to report "noticeable progress" in their pursuit of an integrated clinical trial data-sharing program and mutual acceptance of their rules and guidelines, according to Korea FDA
You may also be interested in...
The Center for Drug Evaluation is making headway to improve the IND process, but it is still a long road ahead.
SHANGHAI - With big pharmaceutical firms increasing their focus on emerging markets, more and more trials are now being conducted across Asia, including China, India, Turkey and South Korea, speakers at World Pharma Trials Asia 2010 said Sept. 14 in Shanghai